Xingjunhao

Junhao Xing, PH.D. Associate Professor at China Pharmaceutical University. Research area is medicinal chemistry, including design of novel targeted molecules and development of novel drug processes. research results have been published in authoritative journals such as Angew. Chem. Int. Ed., ACS Catal., Adv. Synth. Catal., and Eur. J. Med. Dr. Xing has completed the developments of several hot sale drugs such as Apixaban, Rivaroxaban, Tirofiban, Alogliptin. Eight patents have been granted, and one of them has been successfully commercialized.

(1) Qianqian Zhou; Rong Meng; Junhao Xing^#; Weijun Yao; Xiaowei Dou^# ; Rhodium-Catalyzed Chemodivergent Synthesis of Organosilicons Enabled by Controllable C–Si Bond Activation, ACS Catal., 2023, 13(13): 8516-8524

(2) Hu, Yan; Wang, Chenhong; Zhu, Huilong; Junhao Xing^#; Xiaowei Dou^# ; Rhodium-Catalysed Asymmetric Arylation of Pyridylimines, Adv. Synth. Catal., 2022, 364(3): 531-535

(3) Chenhong Wang; Changhui Wu; Yiming Yang; Junhao Xing^#; Xiaowei Dou^#; Rhodium-catalyzed formal [2 + 2 + 1] annulation of arylboronic acids with alkynes, Org. Chem. Front., 2022, 9(24): 6915-6919

(4) Zhiqian Chang; Huilong Zhu; Changhui Wu; Junhao Xing^#; Xiaowei Dou^#; A rhodium-catalysed conjugate addition/ cyclization cascade for the asymmetric synthesis of 2-amino-4H-chromenes, Org. Chem. Front., 2021, 19(4): 785-788

（5）Junhao Xing^#; Wanjiang Zhu; Bihai Ye; Tao Lu; Tamio Hayashi; Xiaowei Dou ; RhodiumCatalyzed Diverse Arylation of 2,5-Dihydrofuran: Controllable Divergent Synthesis via Four Pathways, ACS Catal., 2020, 10(5): 2958-2963

Development of anti-fibrotic drugs; Development of novel drug processes